India's diverse geographical and climatic conditions make it a hotspot for various vector-borne diseases (VBDs). These diseases, transmitted by vectors like mosquitoes, ticks, and fleas, pose a significant public health challenge, straining the healthcare system.
India carries a high burden of VBDs, including malaria, dengue, chikungunya, and Japanese encephalitis. Malaria alone accounts for 89% of the South-East Asia region's cases, with India contributing significantly. Dengue, with its four serotypes, poses challenges due to its increasing incidence and geographical spread.
VBDs not only lead to high morbidity and mortality but also have significant socioeconomic consequences. They disproportionately affect the poor, exacerbating health inequities. Furthermore, they cause substantial economic loss due to medical costs and productivity loss.
Controlling VBDs in India is fraught with challenges. These include inadequate vector control, gaps in disease surveillance, lack of effective diagnostics and vaccines, and issues related to climate change and urbanization. Resistance to insecticides, coupled with a lack of public awareness, further complicates the situation.
Effective VBD control necessitates a multipronged approach. This includes strengthening surveillance, promoting research for new tools, enhancing vector control, and fostering community participation. The role of healthcare professionals in early diagnosis, appropriate management, and patient education is crucial.
Vector-borne diseases continue to be a significant burden in India, necessitating urgent attention. A comprehensive approach, involving healthcare professionals, policymakers, researchers, and the community, is essential to mitigate their impact. As healthcare professionals, understanding the magnitude of this issue is the first step towards contributing to its resolution.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation